At a glance
- Hormone imbalance affects millions of women and is frequently misdiagnosed
- Many signs, from brain fog to gut problems, are rarely linked to hormones
- Early testing and intervention can prevent long-term complications
- Which tests make sense depends on your signs, and the table below links each sign to a sensible first test
What is hormone imbalance?
Hormone imbalance is a sustained shift in one or more hormones (thyroid, cortisol, insulin, estrogen, progesterone, testosterone) outside the range your body needs, producing symptoms even when a single lab value still reads as normal.
Free interactive tool
Hormone signs checklist
Tick the signs you recognize to see the hormones and first tests this article's table links them to.
Hormones are chemical messengers produced by glands throughout the body, including the thyroid, adrenal glands, ovaries, and pituitary gland. They regulate nearly every system in the body: metabolism, sleep, mood, reproduction, digestion, and more.
When these hormones fall out of balance, even slightly, the effects can be far-reaching. Yet the symptoms are varied and overlap with other conditions. That makes hormone imbalance one of the most under-recognized issues in women's health.
Hormonal changes are common, and many women never receive a formal diagnosis.
How common the patterns behind these signs are
Figures quoted in this article, each from the source named in the References, sorted from most to least common. Each bar is a share of a different group, named on its left. Where the source gives a range, the solid part reaches the lower figure and the lighter part carries the rest.
Understanding the warning signs is the first step toward getting the right answers.
Why hormone imbalance is so often missed
Most of the common signs of hormone imbalance (fatigue, mood changes, weight fluctuation, poor sleep) are easy to put down to stress, aging, or a busy lifestyle. That makes it easy for you, and for your clinician, to overlook the hormonal root cause.
Women report this happening. A November 2025 survey asked more than 1,000 US women aged 30 to 60 about perimenopause. Nearly 40% felt they had been misdiagnosed, and 33% had been diagnosed with anxiety. The survey was commissioned by Biote, a hormone therapy company. Read it as a signal about how women experience diagnosis, not as prevalence data.
Compounding the issue, standard blood tests do not always catch subclinical hormonal dysfunction. A TSH result within the "normal" range, for example, may still be suboptimal for your physiology.
Thyroid guidance is also less settled than it looks. The American Thyroid Association's newest guideline, published in May 2026, covers preconception, pregnancy and the months after birth, and its TSH targets are specific to those stages (Korevaar et al., 2026). It does not set the threshold for everyone else, and the association has not updated its general hypothyroidism guideline since 2014. What a borderline result means for you is a decision for your own clinician.
The result: women spend years managing individual symptoms without ever addressing the underlying cause. If you are in your late 30s or 40s and recognize these patterns, our guide to the hidden symptoms of perimenopause covers the ones most often missed, and our guide to balancing hormones naturally covers what lifestyle changes can and cannot do.
10 signs of hormone imbalance in women
1. Persistent fatigue that sleep does not fix
Feeling exhausted despite a full night's sleep is one of the most common, and most overlooked, signs of hormonal dysfunction.
Why it happens: Your thyroid gland sets the speed of your metabolism. When it underproduces thyroid hormones (T3 and T4), every cell in your body slows down. Less commonly, the adrenal glands make too little cortisol. That condition, adrenal insufficiency, also causes fatigue, and it is diagnosed with specific blood tests (Bornstein et al., 2016).
What the research says: In a Danish population study of people newly diagnosed with hypothyroidism, 81% reported tiredness, the most common symptom (Carlé et al., 2014). Some people stay tired even once their thyroid results are back in range, which is worth raising with your clinician.
Many of those thyroid problems are never identified. A July 2025 NHANES analysis in the Journal of the Endocrine Society estimated that 11.6 million US adults have autoimmune thyroid disease. Of those, 8.8 million are women. Prevalence was 7.7% in women against 2.7% in men, drawn from the 2007 to 2012 survey cycles. The authors estimate that about 2.5 million of those women have not been diagnosed.
When to suspect it: Fatigue out of proportion to your activity level, unresponsive to rest, and accompanied by other signs on this list. That pattern warrants a thyroid panel, with cortisol testing if your clinician suspects an adrenal cause.
2. Unexplained weight gain or difficulty losing weight
If your weight is increasing, or stubbornly refusing to budge, despite no changes to diet or exercise, a hormonal cause deserves serious consideration.
Why it happens: Thyroid hormone deficiency slows your metabolic rate. Insulin resistance impairs your body's ability to use glucose efficiently, and it often accompanies the elevated androgens of PMOS (PCOS), the condition renamed from polycystic ovary syndrome in 2026. Cortisol plays a part in where the body stores fat, though the evidence on everyday cortisol levels and weight is mixed.
What the research says: A systematic review of cortisol and obesity found that greater abdominal fat is linked to a more reactive stress-hormone system in many studies, but concluded that the evidence so far is inconclusive (Incollingo Rodriguez et al., 2015). That is why thyroid function and insulin resistance are the first things to rule out.
When to suspect it: Abdominal weight gain without dietary changes, accompanied by fatigue, irregular periods, or skin changes.
3. Sleep problems that come out of nowhere
Struggling to fall asleep, waking repeatedly, or sleeping nine hours and still feeling exhausted are hallmarks of hormonal sleep disruption.
Why it happens: Estrogen supports sleep cycle stability, and progesterone has a sedative-like effect. When these decline, in perimenopause or luteal phase defects, your sleep architecture is disrupted. A dysregulated cortisol rhythm also prevents the physiological "switch off" you need for sleep onset.
What the research says: In a SWAN survey of 12,603 women aged 40 to 55, 38% reported difficulty sleeping, rising to 45.4% in late perimenopause (Kravitz et al., 2003). A later SWAN analysis linked hot flashes and falling estradiol to more trouble falling and staying asleep (Kravitz et al., 2008).
When to suspect it: Sleep problems beginning during a hormonal transition, or consistently worsening in the second half of the menstrual cycle.
4. Mood changes, anxiety, or unexplained irritability
Mood shifts that feel disproportionate or reliably worsen at certain points in the cycle are a well-established sign of hormonal imbalance.
Why it happens: Estrogen modulates serotonin and dopamine availability. Low progesterone reduces GABAergic activity, your brain's primary calming mechanism, producing anxiety and irritability.
What the research says: A study in the New England Journal of Medicine found that in women with premenstrual syndrome, symptoms reflect an abnormal response to normal hormone changes, rather than abnormal hormone levels (Schmidt et al., 1998). That is a critical clinical distinction.
When to suspect it: Predictable cycle-linked mood symptoms, or mood changes failing to respond to standard treatments for anxiety or depression.
5. Irregular, missed, or unusually heavy periods
Changes to your cycle are among the most direct indicators of hormonal disruption.
Why it happens: Any disruption to the hormonal sequence governing ovulation alters your cycle, whether from elevated prolactin, thyroid dysfunction, androgen excess, or hypothalamic suppression. When a cycle passes without ovulation, progesterone stays low and the uterine lining can build up and shed irregularly or heavily. Doctors classify the causes of abnormal bleeding with the FIGO system, which also includes polyps, fibroids and adenomyosis (Munro et al., 2018). Absent periods may indicate PCOS or hypothalamic amenorrhea.
What the research says: According to the World Health Organization, PCOS affects an estimated 10 to 13% of women of reproductive age, and up to 70% of those affected are undiagnosed.
The name of that condition changed in 2026. An international consensus published in The Lancet in May 2026 renamed it polyendocrine metabolic ovarian syndrome, or PMOS (PCOS). The Endocrine Society said in May 2026 that the old name reduced a complex endocrine disorder to a misunderstanding about cysts. It said the old name contributed to missed diagnoses. PMOS (PCOS) affects one in eight women, more than 170 million worldwide. A three-year transition is underway, with full implementation in the 2028 guideline update.
When to suspect it: Any persistent change to a previously regular cycle in frequency, duration, volume, or pain level.
6. Hormonal acne, dry skin, or sudden changes in skin texture
Your skin is one of the most sensitive reflectors of hormonal status.
Why it happens: Androgen excess drives sebum overproduction, causing cystic acne concentrated along the jawline and chin. That pattern is characteristically different from adolescent acne. Estrogen deficiency reduces collagen and impairs your skin's moisture barrier. Thyroid dysfunction produces its own distinct skin changes.
What the research says: The American Academy of Dermatology's 2024 acne guideline, published in the Journal of the American Academy of Dermatology, does not recommend routine hormonal testing for everyone. It conditionally recommends spironolactone and combined oral contraceptives for acne in women. That is why jawline acne alongside irregular cycles or excess hair growth is worth a hormonal workup, which may include testosterone, DHEA-S and SHBG.
When to suspect it: Cystic lower-face acne worsening premenstrually, or skin becoming notably drier or thinner without a change in routine.
7. Hair thinning or unwanted hair growth
Hair changes are among the most distressing and most commonly dismissed signs of hormonal imbalance.
Why it happens: Androgenic alopecia presents as diffuse crown thinning. Thyroid dysfunction and iron deficiency (often from heavy menstrual loss) trigger telogen effluvium. Hirsutism, meaning coarse hair on the face, chest, or abdomen, is a direct marker of androgen excess.
What the research says: A 2025 meta-analysis of 24 studies in JAAD International estimated that 32.3% of women with female pattern hair loss have PMOS (PCOS), though the authors rate that figure as very low certainty. The same analysis found female pattern hair loss in 22.7% of women with PMOS (PCOS). An analysis of 172,401 women in the All of Us research program found hirsutism in 19.12% of those with PMOS (PCOS), compared with 1.37% overall. Both changes are underreported in clinical consultations.
Thyroid status shapes how severe the shedding gets. A January 2024 study in Medicine looked at 500 women with telogen effluvium. It compared 150 women with hypothyroidism, 102 with hyperthyroidism, and 248 with normal thyroid function. The hypothyroid group had the most severe shedding.
When to suspect it: Diffuse thinning, a widening center part, excessive daily shedding, or new coarse facial or body hair.
8. Brain fog, poor memory, and difficulty concentrating
Cognitive sluggishness is routinely dismissed as stress. In many cases, the cause is hormonal.
Why it happens: Estrogen supports synaptic plasticity, cerebral blood flow, and acetylcholine production. When it declines, your processing can slow. Hypothyroidism also slows mental speed.
What the research says: A SWAN study followed 2,362 women for four years. During perimenopause, the gains in memory and processing speed that women normally make with practice stalled, then returned after menopause (Greendale et al., 2009).
When to suspect it: Cognitive symptoms emerging during a hormonal transition, or occurring alongside fatigue, mood changes, or cycle disruption.
9. Digestive issues that worsen around your period
Gut symptoms that follow your cycle are often linked to hormonal changes, not coincidence.
Why it happens: Progesterone slows intestinal motility, worsening constipation in the luteal phase. At menstruation, prostaglandin release causes diarrhea and gut cramping beyond the uterus. If you have IBS, you are particularly vulnerable to these hormonally driven fluctuations.
What the research says: A 2026 study in Neurogastroenterology and Motility screened 3,521 girls aged 10 to 16 in Colombia. Among the girls who met criteria for irritable bowel syndrome, 62.2% had pain and bowel changes only during their period. An analysis of 14,570 people with gut-brain disorders from the Rome Foundation's 26-country survey also found women reporting symptoms more often than men.
When to suspect it: Digestive symptoms reliably worsening before or during your period, or emerging alongside a hormonal change.
10. Low libido and genitourinary symptoms
A sustained drop in sexual desire, once psychological factors have been ruled out, is a recognized sign of hormonal deficiency. It is frequently under-reported.
Why it happens: Testosterone plays a critical role in female libido, energy, and wellbeing. It declines steadily with age and sharply after surgical menopause. Estrogen deficiency produces Genitourinary Syndrome of Menopause (GSM): vaginal dryness, dyspareunia, and recurrent UTIs. The 2025 AUA, SUFU and AUGS guideline puts reported prevalence of GSM at 13 to 87%.
What the research says: The 2025 genitourinary syndrome of menopause guideline from the AUA, SUFU and AUGS reports that only about half of affected women raise the symptoms with a clinician. The guideline recommends local low-dose vaginal estrogen, including to reduce recurrent urinary tract infections. Whether that fits your situation is a decision for your own clinician.
The treatment picture shifted recently. On 15 December 2025 the FDA extended the approval of Addyi (flibanserin) for hypoactive sexual desire disorder to women under 65 regardless of menopause status, which adds postmenopausal women under 65. No testosterone product is FDA approved for women.
When to suspect it: Gradual libido decline following a hormonal transition; vaginal dryness or discomfort; recurrent UTIs without a clear cause.
Which sign points to which hormone
Each sign above maps to a small set of hormones and a sensible first test.
| Sign | Hormones involved | First test to ask about |
|---|---|---|
| 1. Fatigue that sleep does not fix | Thyroid hormones (T3 and T4), cortisol | Full thyroid panel, cortisol |
| 2. Unexplained weight gain | Cortisol, thyroid hormones, insulin, androgens | Fasting glucose and insulin, thyroid panel |
| 3. Sleep problems | Estrogen, progesterone, cortisol | Estradiol, progesterone, cortisol rhythm |
| 4. Mood changes, anxiety, irritability | Estrogen, progesterone | Estradiol and progesterone, timed to your cycle |
| 5. Irregular, missed, or heavy periods | Progesterone, estrogen, prolactin, androgens, thyroid hormones | Prolactin, TSH, FSH, LH |
| 6. Hormonal acne and skin changes | Androgens, estrogen, thyroid hormones | Testosterone, DHEA-S, SHBG |
| 7. Hair thinning or unwanted hair growth | Androgens, thyroid hormones | Total and free testosterone, thyroid panel |
| 8. Brain fog and poor memory | Estrogen, thyroid hormones, cortisol | Estradiol, TSH, free T3, free T4 |
| 9. Digestive issues around your period | Progesterone, prostaglandins | Progesterone, timed to the luteal phase |
| 10. Low libido and genitourinary symptoms | Testosterone, estrogen | Total and free testosterone, estradiol |
These are starting points, not a diagnosis. Which tests you need is a decision for your own clinician. Interlinked Wellness offers hormone testing, including the tests listed here.
Interactive tool
Hormone signs checklist
Tick the signs you recognize to see the hormones and first tests the table above links them to.
Frequently asked questions
Can I have hormone imbalance even if my blood tests come back normal?
Yes. Standard reference ranges are broad, and you can fall within them while still experiencing significant symptoms. Comprehensive testing (including free hormone levels, SHBG, and fasting insulin) combined with clinical assessment gives you a more complete picture.
What causes hormone imbalance in women?
Common causes include chronic stress, thyroid dysfunction, PCOS, perimenopause, nutritional deficiencies, insulin resistance, excess body fat, and certain medications. In many cases, multiple factors are involved simultaneously.
What tests should I ask for?
It depends on which signs you have, and the table above links each sign to a sensible first test. Depending on your history, a first-line panel may include FSH, LH, estradiol, progesterone, total and free testosterone, SHBG, and prolactin, thyroid function (TSH, free T3, free T4, and thyroid antibodies), and fasting glucose and insulin. Ask your clinician what each test will tell you.
Can hormone imbalance be treated without medication?
In many cases, yes, particularly early on. Sleep optimization, stress reduction, dietary changes, and targeted nutritional support can significantly improve your hormonal balance. However, conditions such as hypothyroidism, PCOS, or menopausal hormone deficiency often benefit from medical treatment. Always consult a qualified clinician first.
One labeling change is worth knowing about. On 10 November 2025 the FDA asked manufacturers to remove the heart disease, breast cancer and dementia statements from the boxed warnings on menopausal hormone therapy. The endometrial cancer warning stays on systemic estrogen-alone products. This changes how these medicines are labeled. It is not a recommendation that you take them, and that decision belongs with your clinician.
At what age does hormone imbalance typically begin?
There is no single age. PCOS and thyroid dysfunction can begin in the teens or twenties. Perimenopause typically begins in the forties but can start earlier. If symptoms are present and persistent, age should not delay evaluation.
Key Takeaways
- Hormone imbalance produces a wide range of symptoms frequently put down to stress, aging, or other conditions.
- The ten signs covered here are common and easy to put down to stress or age: fatigue, weight changes, sleep disruption, mood disturbance, cycle irregularity, skin changes, hair changes, brain fog, digestive symptoms, and low libido.
- Symptoms rarely appear in isolation. Multiple concurrent signs significantly raise clinical suspicion.
- Standard blood tests may miss subclinical dysfunction. Testing guided by your signs, and read alongside your symptoms, gives the clearest picture.
- Early identification enables targeted intervention before symptoms progress.
When to seek clinical evaluation
If you are experiencing two or more of the signs above, particularly if they are persistent, progressive, or clustered, seek evaluation. Look for a clinician with expertise in endocrinology, gynecology, or integrative medicine. You do not need to accept these symptoms as normal. They are not inevitable features of being a woman or getting older. They are signals worth investigating.
Getting support
Interlinked Wellness supports women with hormone changes and related symptoms across Texas by telehealth, with clinics in Dallas and Austin. If several of these signs sound familiar, book a consultation.
Updated 8 October 2026: corrected several figures and sources, and added 2026 developments on the PCOS renaming, thyroid guidance and FDA labeling.
References
- Biote. Business Wire. 2025. https://www.businesswire.com/news/home/20251113649089/en/
- Korevaar TIM, et al. American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. Thyroid. 2026. https://pubmed.ncbi.nlm.nih.gov/42219800/
- Bornstein SR, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency. The Journal of Clinical Endocrinology and Metabolism. 2016. https://pubmed.ncbi.nlm.nih.gov/26760044/
- Carlé A, et al. European Journal of Endocrinology. 2014. https://pubmed.ncbi.nlm.nih.gov/25305308/
- Dillon CF, et al. Journal of the Endocrine Society. 2025. https://academic.oup.com/jes/article/9/10/bvaf120/8204439
- Incollingo Rodriguez AC, et al. Psychoneuroendocrinology. 2015. https://pubmed.ncbi.nlm.nih.gov/26356039/
- Kravitz HM, et al. Menopause. 2003. https://pubmed.ncbi.nlm.nih.gov/12544673/
- Kravitz HM, et al. Sleep. 2008. https://pubmed.ncbi.nlm.nih.gov/18652093/
- Schmidt PJ, et al. New England Journal of Medicine. 1998. https://pubmed.ncbi.nlm.nih.gov/9435325/
- Munro MG, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes. International Journal of Gynecology and Obstetrics. 2018. https://pubmed.ncbi.nlm.nih.gov/30198563/
- World Health Organization. Polycystic ovary syndrome fact sheet. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
- Endocrine Society. Press release on the renaming of PCOS to polyendocrine metabolic ovarian syndrome. 2026. https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
- Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026. https://pubmed.ncbi.nlm.nih.gov/42119588/
- American Academy of Dermatology acne guideline. Journal of the American Academy of Dermatology. 2024. https://pubmed.ncbi.nlm.nih.gov/38300170/
- Rayner DG, et al. JAAD International. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12481967/
- Chen M, et al. Journal der Deutschen Dermatologischen Gesellschaft. 2025. https://pubmed.ncbi.nlm.nih.gov/39865752/
- Bin Dayel S, et al. Medicine. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10766245/
- Greendale GA, et al. Neurology. 2009. https://pubmed.ncbi.nlm.nih.gov/19470968/
- Arrizabalo S, et al. Neurogastroenterology and Motility. 2026. https://pubmed.ncbi.nlm.nih.gov/42333039/
- Sarnoff RP, et al. Neurogastroenterology and Motility. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11748819/
- American Urological Association, SUFU and AUGS. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline. 2025. https://www.auanet.org/guidelines-and-quality/guidelines/genitourinary-syndrome-of-menopause
- U.S. Food and Drug Administration. Approval letter, Addyi (flibanserin), NDA 022526/S-013. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/022526Orig1s013ltr.pdf
- U.S. Food and Drug Administration. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies. 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations
About the author
Anna Evans MSN, APRN, FNP-C
Founder, Interlinked Wellness
Anna Evans, MSN, APRN, FNP-C is a board-certified Family Nurse Practitioner licensed in Texas. She founded Interlinked Wellness, a virtual functional medicine practice serving women across Texas from offices in Dallas and Austin. Her clinical focus is perimenopause, hormone imbalance, gut health, thyroid and autoimmune conditions, and chronic fatigue.
More about Anna · Schedule a consultation · LinkedIn · Instagram
Medical Disclaimer
The information on this page is provided for general education and is not individualized medical advice. At Interlinked Wellness, Anna Evans, MSN, APRN, FNP-C, provides personalized care based on your health history, symptoms, concerns, and goals. An individual consultation allows Anna to evaluate your specific situation and recommend an appropriate approach to care. Reading this page alone does not establish a patient-provider relationship. If you are experiencing a medical emergency, call 911 or your local emergency services.
Join Anna on a virtual wellness journey and unlock your full potential.
